Oisin Biotechnologies

Oisín is a private biotechnology company developing genetic medicines to address age-related diseases. Headquartered in Seattle, Washington, Oisín utilizes Fusogenix Protein Lipid Vehicle (PLV) technology to deliver DNA directly into cells throughout the body, targeting the damage and adverse effects caused by the aging process itself. The company's first therapy focuses on eliminating unwanted fat cells and increasing muscle mass.